Nathan Foulquier is a PhD student in artificial intelligence at University of Western Brittany, France, and member of the Laboratory of Medical Information Processing (LATIM, University of Brest), France. His research focuses on natural language processing and deep learning in a biomedical context, especially autoimmune diseases.
Browse topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA
Anifrolumab for the treatment of SLE
JAK inhibitor safety: Weighing up the data and understanding the risks
Rituximab and rheumatology practice in the COVID-19 era
Safety snapshot: Upadacitinib in patients with PsA
Repurposing rheumatology drugs for COVID-19
Telemedicine in rheumatology: COVID-19 and beyond
Managing PsA in resource-limited settings
Conferences